Wegovy, with the active ingredient semaglutide, is a once-weekly GLP-1 medication delivered via a pre-filled injection pen or daily tablet
For example, in the STEP-1 clinical trial, participants taking semaglutide lost an average of 11.6 pounds of lean body mass compared to just 4 pounds in the placebo group
Break it down month by month and the picture becomes clearer: Month 1: $279 (introductory rate at 2.5mg) Months 2 to 3: $399/month (dose escalation through 5mg to 7.5mg) Months 4 to 6: $449 to $499/month (maintenance doses at 10mg to 15mg) Months 7 to 12: $449 to $499/month (ongoing maintenance) Over twelve months, that totals approximately $5,100 to $5,700
Post-surgical recovery is a separate but related category
To view a copy of this licence, visit About this article Cite this article Tang, D., Kang, R